ADVFN - Advanced Financial Network.
HOME» NYSE » P » PKI Stock Price » PKI Stock News

Perkin Elmer Share News

 Perkinelmer, Inc. Stock Price
PKI Stock Price
 Perkinelmer, Inc. Stock Chart
PKI Stock Chart
 Perkinelmer, Inc. Stock News
PKI Stock News
 Perkinelmer, Inc. Company Information
PKI Company Information
 Perkinelmer, Inc. Stock Trades
PKI Stock Trades

PerkinElmer Boosts Software Offerings In 2 Deals Valued At $220 Million

DOW JONES NEWSWIRES PerkinElmer Inc. (PKI) signed a definitive agreement to acquire software and database company CambridgeSoft Corp. and completed its purchase of software firm ArtusLabs Inc., deals together valued at $220 million. The acquisitions carry an added contingent payment of up to $15 million. The deals are expected to boost PerkinElmer's adjusted earnings for the rest of the year by about 4 cents a share. PerkinElmer, which sells analytical products and services to the health-care and industrial sectors, has seen strong revenue growth lately, helped by its environmental health division. Revenue also has increased in its human-health division. Last month, it reported its fourth-quarter earnings soared as it booked a $315.3 million gain on the disposition of discontinued operations. For 2011, CambridgeSoft and ArtusLabs together expect revenue of about $65 million. The deal for CambridgeSoft is expected to close in the second quarter. CambridgeSoft offers desktop software and scientific databases, among other things, to the pharmaceutical, biotechnology and chemical industries, while ArtusLabs' flagship product, Ensemble, blends social networking and data mining. PerkinElmer shares recently rose 0.7% to $26 premarket. The stock is up 7.7% in the past 52 weeks. -By Lauren Pollock, Dow Jones Newswires; 212-416-2356;

Stock News for Perkin Elmer (PKI)
03/21/201716:06:49Statement of Changes in Beneficial Ownership (4)
03/15/201716:12:55Statement of Changes in Beneficial Ownership (4)
03/15/201716:12:29Statement of Changes in Beneficial Ownership (4)
03/08/201708:03:40Additional Proxy Soliciting Materials (definitive) (defa14a)
03/08/201708:02:17Proxy Statement (definitive) (def 14a)
02/28/201718:43:06Annual Report (10-k)
02/22/201716:07:11Statement of Changes in Beneficial Ownership (4)
02/21/201716:06:40Statement of Changes in Beneficial Ownership (4)
02/16/201716:15:00Perkinelmer to Present at Barclays Capital Global Healthcare...
02/16/201716:07:43Statement of Changes in Beneficial Ownership (4)
02/13/201717:31:22Amended Statement of Ownership (sc 13g/a)
02/13/201715:13:31Statement of Ownership (sc 13g)
02/10/201716:30:49Statement of Changes in Beneficial Ownership (4)
02/10/201716:14:46Amended Statement of Ownership (sc 13g/a)
02/10/201716:07:50Statement of Changes in Beneficial Ownership (4)
02/08/201718:00:34Statement of Changes in Beneficial Ownership (4)
02/08/201717:39:20Statement of Changes in Beneficial Ownership (4)
02/08/201717:34:59Statement of Changes in Beneficial Ownership (4)
02/08/201717:34:59Statement of Changes in Beneficial Ownership (4)
02/08/201717:28:28Statement of Changes in Beneficial Ownership (4)

Perkin Elmer and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations